New brain cancer combo aims to outsmart Tumor's defenses
NCT ID NCT05879250
Summary
This study is testing whether adding an experimental drug called WP1066 to standard radiation therapy can better control a fast-growing type of brain cancer called glioblastoma. The drug is designed to block a specific pathway that helps the tumor grow and hide from the body's immune system. Researchers will measure if this combination helps slow the cancer's progression and helps patients live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA, IDH-WILDTYPE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern Medicine: Warrenville
ACTIVE_NOT_RECRUITINGWarrenville, Illinois, 60555, United States
-
Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.